Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Delayed emesis: moderately emetogenic chemotherapy.

Fausto Roila1, David Warr, Rebecca A Clark-Snow

  • 1Medical Oncology Division, Policlinico Hospital, 06122 Perugia, Italy. roila.fausto@libero.it

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|November 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study.

EClinicalMedicine·2026
Same author

Quantitative Assessment of Seminoma in the Testicle Among Nonseminomatous Germ Cell Tumor Patients on Operative Difficulty, Morbidity and Pathological Outcomes at Postchemotherapy RPLND.

Clinical genitourinary cancer·2026
Same author

Adverse COVID-19 experiences and physical and psychological outcomes in patients with lung cancer.

Palliative & supportive care·2026
Same author

Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.

JCO precision oncology·2026
Same author

Renal Impairment and Late Toxicities Comparing Contemporary Chemotherapy Regimens for Testicular Cancer in a Real-World Setting.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Clinical stage IIA/B embryonal carcinoma predominant nonseminomatous germ cell tumor: Minimizing treatment burden.

Urologic oncology·2026

Limited data exists on preventing delayed chemotherapy-induced nausea and vomiting. Dexamethasone shows promise, but optimal use is unclear, while 5-HT(3) antagonists and dopamine receptor antagonists have weak evidence for delayed emesis.

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Medicine

Background:

  • Delayed nausea and vomiting are common side effects of moderately emetogenic chemotherapy.
  • Current data on antiemetic prophylaxis for delayed emesis is limited.
  • Effective management strategies for this patient group require further investigation.

Purpose of the Study:

  • To review the existing literature on the efficacy of antiemetic prophylaxis for delayed chemotherapy-induced nausea and vomiting.
  • To assess the effectiveness of dexamethasone, 5-HT(3) antagonists, and dopamine receptor antagonists in preventing delayed emesis.

Main Methods:

  • A literature overview was conducted, focusing on randomized trials evaluating antiemetic prophylaxis.
  • Data on the incidence and efficacy of specific antiemetic agents were analyzed.

Related Experiment Videos

Main Results:

  • Dexamethasone demonstrated efficacy in two out of three randomized trials, but optimal dosing and duration remain undefined.
  • Only one of four randomized studies showed statistically significant efficacy for 5-HT(3) antagonists.
  • Evidence supporting the efficacy of dopamine receptor antagonists for delayed emesis is weak.

Conclusions:

  • Dexamethasone is a potential agent for managing delayed chemotherapy-induced nausea and vomiting, warranting further research into optimal regimens.
  • Current evidence for the efficacy of 5-HT(3) antagonists and dopamine receptor antagonists in preventing delayed emesis is insufficient.
  • More robust clinical trials are needed to establish effective antiemetic prophylaxis strategies for delayed emesis.